Science Explorer Back to mapMap
Discussion
Company · Paterna · Spain

Valentia Biopharma (Spain)

valentiabiopharma.comROR OpenAlex
Research works
4
▲ 66% vs 2018-21
Citations
19
4.9 per fractional work
Top-10% rate
8.1%
all institutions 10.0%
Open access
75%
world 40%
International
25%
world 18%
Valentia Biopharma (Spain)

Not ranked overall: Valentia Biopharma (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Valentia Biopharma (Spain) work in?

In all years, 50% of research at Valentia Biopharma (Spain) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (21%), Medicine (18%), Agricultural and Biological Sciences (16%). It does 1.4× the world's share of Life Sciences.

Life Sciences: 2 fractional works · 50.0% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 21.1% of its workAgricultural and Biological Sciences: 1 fractional works · 15.8% of its workNeuroscience: 0 fractional works · 10.5% of its workImmunology and Microbiology: 0 fractional works · 2.6% of its workHealth Sciences: 1 fractional works · 36.8% of its workMedicine: 1 fractional works · 18.4% of its workHealth Professions: 0 fractional works · 7.9% of its workDentistry: 0 fractional works · 5.3% of its workVeterinary: 0 fractional works · 5.3% of its workSocial Sciences: 0 fractional works · 10.5% of its workPsychology: 0 fractional works · 7.9% of its workSocial Sciences: 0 fractional works · 2.6% of its workPhysical Sciences: 0 fractional works · 2.6% of its workComputer Science: 0 fractional works · 2.6% of its workALL ITS WORKValentiaBiopharma (Spain)4fractional works, all years
Life Sciences50%Physical Sciences3%Health Sciences37%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology121.1%
    2. Agricultural and Biological Sciences115.8%
    3. Neuroscience010.5%
    4. Immunology and Microbiology02.6%
    1. Medicine118.4%
    2. Health Professions07.9%
    3. Dentistry05.3%
    4. Veterinary05.3%
    1. Psychology07.9%
    2. Social Sciences02.6%
    1. Computer Science02.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.57× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.79× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 8.88× its world share, 0 worksImmunology and Micro…Neuroscience: 4.59× its world share, 0 worksNeuroscienceMedicine: 2.22× its world share, 1 worksMedicineVeterinary: 82.23× its world share, 0 worksVeterinaryPsychology: 2.44× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 82.2×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Veterinary82.23×0 works
  2. Immunology and Microbiology8.88×0 works
  3. Neuroscience4.59×0 works
  4. Biochemistry, Genetics and Molecular Biology2.79×0 works
  5. Psychology2.44×0 works
  6. Medicine2.22×1 works
  7. Agricultural and Biological Sciences1.57×0 works

What are the most cited papers from Valentia Biopharma (Spain)?

The most cited paper from Valentia Biopharma (Spain) is "(CCUG)n RNA toxicity in a Drosophila model for myotonic dystrophy type 2 (DM2) activates apoptosis" (Vildan Betül Yenigun, Mario Sirito, Alla Amcheslavky et al., 2017), with 14 citations. Next come "Development of aDrosophila melanogasterspliceosensor system forin vivohigh-throughput screening in myotonic dystrophy type 1" (14) and "Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers" (10).

Most cited papers
#PaperReleasedCitations
1 (CCUG)n RNA toxicity in a Drosophila model for myotonic dystrophy type 2 (DM2) activates apoptosis Vildan Betül Yenigun, Mario Sirito, Alla Amcheslavky et al. · Disease Models & Mechanisms Open access 2017 14
2 Development of aDrosophila melanogasterspliceosensor system forin vivohigh-throughput screening in myotonic dystrophy type 1 Irma García-Alcover, Jordi Colonques-Bellmunt, Raquel Garijo et al. · Disease Models & Mechanisms Open access 2014 14
3 Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers Juan M. Fernández‐Costa, Beatriz Llamusí, Ariadna Bargiela et al. · PLoS ONE Open access 26 Feb 2016 10
4 Replacement of the myotonic dystrophy type 1 CTG repeat with ‘non-CTG repeat’ insertions in specific tissues Michelle Axford, Arturo López Castel, Masayuki Nakamori et al. · Journal of Medical Genetics Open access 27 May 2011 9
5 Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSALR Mice Mari Carmen Álvarez-Abril, Irma García-Alcover, Jordi Colonques-Bellmunt et al. · International Journal of Molecular Sciences Open access 6 Jun 2023 6
All 8 most cited papers, with filters and sorting

Which research topics does Valentia Biopharma (Spain) publish most on?

By volume in 2022-now: Infectious Disease Case Reports and Treatments, Actinomycetales infections and treatment, Infectious Diseases and Mycology and Microbial infections and disease research.

Infectious Disease Case …0Infectious Disease Case Reports and Treatments: 0 fractional worksActinomycetales infectio…0Actinomycetales infections and treatment: 0 fractional worksInfectious Diseases and …0Infectious Diseases and Mycology: 0 fractional worksMicrobial infections and…0Microbial infections and disease research: 0 fractional worksRabies epidemiology and control: 0 fractional worksStreptococcal Infections and Treatments: 0 fractional worksDermatological diseases …0Dermatological diseases and infestations: 0 fractional worksSignaling Pathways in Disease: 0 fractional worksGenetic Neurodegenerative Diseases: 0 fractional worksIon channel regulation a…0Ion channel regulation and function: 0 fractional works
Infectious DiseasesMicrobiologySmall AnimalsVirology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Infectious Disease Case Reports and Treatments Infectious Diseases 0 works
  2. 2 Actinomycetales infections and treatment Microbiology 0 works
  3. 3 Infectious Diseases and Mycology Small Animals 0 works
  4. 4 Microbial infections and disease research Microbiology 0 works
  5. 5 Rabies epidemiology and control Virology 0 works
  6. 6 Streptococcal Infections and Treatments Public Health, Environmental and Occupational Health 0 works
  7. 7 Dermatological diseases and infestations Infectious Diseases 0 works
  8. 8 Signaling Pathways in Disease Molecular Biology 0 works
  9. 9 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  10. 10 Ion channel regulation and function Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available75.1%not open24.9%

World: 40% of research is openly available.

with international co-authors25.4%domestic only74.6%

World: 18% is written across borders.

How has Valentia Biopharma (Spain)'s research output changed?

Output in 2022-2025 was 66% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Paterna

All research institutions in Paterna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Valentia Biopharma (Spain). Posts are plain text and can be reported.